Farag Kameel D. bought AKTX
August 17, 2026 · Form 4 insider transaction
Farag Kameel D. bought 1,728 shares of Akari Therapeutics, Plc at $7.52 per share, a transaction worth $13.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,728
Price
$7.52
Total value
$13.0K
InsiderFarag Kameel D.
Role—
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeA: Grant or award
Transaction dateAugust 17, 2026
Filing dateAugust 19, 2026
Shares owned after23,309
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on September 15, 2026.